Novel Mad2-targeting miR-493-3p controls mitotic fidelity and cancer cells’ sensitivity to paclitaxel

Mahesh Tambe, Sofia Pruikkonen, Jenni Mäki-Jouppila, Ping Chen, Bente Vilming Elgaaen, Anne Hege Straume, Kaisa Huhtinen, Olli Cárpen, Per Eystein Lønning, Ben Davidson, Sampsa Hautaniemi, Marko J. Kallio

Oncotarget (2016)

Published on December 4, 2025

DOI: https://doi.org/10.18632/oncotarget.7860

← Back to Publications
O. Parilova et al. • 2026 • Nucleic Acids Research
Abstract RNA polymerase I (Pol I) synthesizes precursor ribosomal RNA, a key step in ribosome biogenesis. Elevated Pol I activity...
M. Gluud et al. • 2026 • Allergy
ABSTRACT Background Skin barrier dysfunction is central to inflammation and susceptibility to infection in atopic dermatitis (AD). Cutaneous T‐cell lymphoma...
G. Follain et al. • 2026 • The EMBO Journal
Abstract The rapid, transient, and unpredictable nature of interactions between circulating cells and the endothelium challenges the investigation of these...